Document is current
Any future updates will be listed below
-
Authors
Shen, Yanhan
Shahn, Zach
Robertson, McKaylee M.
Gebo, Kelly
Nash, Denis
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 24 November 2025
Accepted: 11 May 2026
First Online: 21 May 2026
Declarations
:
: The study was approved by the Institutional Review Boards of the City University Of New York (CUNY) Graduate School of Public Health and Health Policy (New York, NY, U.S.) (protocol 2020 − 0256). Informed consent forms were completed in a web browser on participants’ computer or mobile device at baseline, each round of serological testing, and at periodic follow-up assessments. The study was conducted in accordance with the ethical standards of the CUNY IRB and with the 1964 Declaration of Helsinki and its later amendments (and the U.S. Common Rule, 45 CFR 46).
: Not applicable.
: Author DN receives consulting fees from Gilead Sciences and AbbVie. All other authors have no conflicts of interest, financial or otherwise.
